|1.||Huang, Ling-Li: 2 articles (05/2011 - 03/2011)|
|2.||Yuan, Zong-Hui: 2 articles (05/2011 - 03/2011)|
|3.||Zhou, Wen: 2 articles (05/2011 - 03/2011)|
|4.||Wang, Yu-Lian: 2 articles (05/2011 - 03/2011)|
|5.||Wang, Xu: 2 articles (05/2011 - 03/2011)|
|6.||Liu, Zhen-Li: 2 articles (05/2011 - 03/2011)|
|7.||Ihsan, Awais: 2 articles (05/2011 - 03/2011)|
|8.||Zhou, Shiqi: 2 articles (04/2006 - 01/2006)|
|9.||Fang, Guijie: 2 articles (04/2006 - 01/2006)|
|10.||He, Qinghua: 2 articles (04/2006 - 01/2006)|
|1.||Body Weight (Weight, Body)
01/04/2013 - "Three groups of Kunming mice were respectively given a single dose of cyadox at three different concentrations (100, 650, and 4000 mg/kg body weight) via gavage. "
01/01/2006 - "Except that body weights of both sexes of the 2500 mg/kg cyadox group were significantly lower than controls beginning after the second week of treatment. "
05/01/2011 - "At the 250 mg/kg b.w./day cyadox group, body weights of F(1b) pregnant rats and F(2a) on day 21 after birth decreased; fetal body lengths and tail lengths decreased; the number of fetal resorptions increased significantly; litter weights, number of viable fetuses decreased; number of embryo resorptions increased significantly; number of liveborn F(1a), F(1b) and F(2a) decreased. "
03/01/2011 - "There were significant decreases in body weights in both genders during most of the study period in 2000 mg/kg cyadox and 400 mg/kg olaquindox rats. "
02/01/1990 - "Weight gain was significantly increased in the 200 ppm cyadox group. "
03/01/1984 - "Cyadox in mixture A 1, administered in the fourth and fifth week after the weaning of the piglets, increased weight gains by 14% and reduced feed consumption by 10% without reducing growth rate."
02/01/1990 - "An experiment was designed to study the clinical effects of different levels of carbadox, cyadox and olaquindox in the ration on health, weekly weight gain and feed conversion in pigs. "
|3.||Phototoxic Dermatitis (Phototoxicity)
04/01/2006 - "This study was performed to evaluate the phototoxicity of cyadox on skin. "
04/01/2006 - "The phototoxicity of cyadox was mild and reversible, which demonstrated a good safety profile of cyadox in terms of phototoxicity."
04/01/2006 - "It was reported that the other quinoxaline-1,4-dioxide compounds had phototoxicity, but only few data are reported on phototoxicity of cyadox. "
04/01/2006 - "Experimental evaluation of cyadox phototoxicity to Balb/c mouse skin."
01/01/1992 - "The system of congenic strains of the laboratory rat carrying the mutant allele lx which is determining the polydactyly-luxate syndrome (PLS) was used for testing teratogenicity of six compounds from different pharmacological groups (cyclophosphamide, cyadox, carbadox, imipramine, verapamil, TIA). "
|5.||Marek Disease (Marek's Disease)
02/01/1990 - "Chickens infected with highly virulent Marek's disease virus were administered in the course of 56-day fattening cyadox at a dose of 20 mg per kg feed mixture (MC group). "
02/01/1990 - "Pathologico-anatomical changes typical of Marek's disease were recorded in a randomly selected number of chickens in 33.3% in the control group, in 28.5% in the cyadox-treated group and in 50.0% in the virginiamycin-treated group."
02/01/1990 - "[The effect of cyadox and virginiamycin on Marek's disease in chickens]."
|7.||Anti-Infective Agents (Microbicides)